{"id":212961,"date":"2026-08-20T10:00:10","date_gmt":"2026-08-20T04:30:10","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=212961"},"modified":"2026-08-20T10:00:10","modified_gmt":"2026-08-20T04:30:10","slug":"why-bliss-gvs-pharma-ltd-share-price-52-week-high-2026-08-20","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-ltd-share-price-52-week-high-2026-08-20\/","title":{"rendered":"Bliss GVS Pharma Ltd. (BLISSGVS-BE) Share Price Hits Fresh 52-Week High"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/blissgvs\/bliss-gvs-pharma-ltd-share-price-today\">Bliss GVS Pharma Ltd.<\/a> rose to Rs 595, up 3.89% today, after hitting a fresh 52-week high of Rs 596.95. Its market capitalisation stands at Rs 5,796.78 crore.<\/p>\n<p style=\"margin-top:0!important;\">Bliss GVS Pharma Ltd. Share Price is in focus after the stock climbed to Rs 595, up Rs 22.3 or 3.89% from the previous close of Rs 572.7, and touched a fresh 52-week high of Rs 596.95 in early trade on 20 August 2026. The move places the company among the 52 Week High Stocks being tracked in the Indian Stock Market, with the company\u2019s market capitalisation at Rs 5,796.78 crore.<\/p>\n<p>For investors scanning Bliss GVS Pharma Ltd. Share Price Today and broader Stock Market Today trends, the verified data confirms a clear price event: the stock opened at Rs 582, traded between Rs 580 and Rs 596.95, and reached a new one-year high. Turnover stood at Rs 0.78 crore with current volume of 13,085 shares. The supplied data confirms the breakout in price action, but it does not establish a company-specific catalyst behind the move.<\/p>\n<p>That still makes Bliss GVS Pharma Ltd. Stock News relevant. A fresh yearly high often draws attention because it changes the stock\u2019s trading range, places valuation back under scrutiny, and prompts comparison with sector and peer metrics. In this Univest analysis, the focus is on what the numbers show today, how the stock is valued against the Healthcare benchmark, and what investors may want to monitor next.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Bliss_GVS_Pharma_Ltd_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Bliss GVS Pharma Ltd. Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 595<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 572.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 22.3 (+3.89%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 582<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Fresh 52-Week High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 596.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 580<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13,085<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.78 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,796.78 crore<\/td>\n<\/tr>\n<\/table>\n<p>Bliss GVS Pharma Ltd. (BLISSGVS-BE) traded at Rs 595. versus the previous close of Rs 572.7, a rise of 3.89%. The stock opened at Rs 582, reached Rs 596.95, touched Rs 580. Reported volume was 13,085.<\/p>\n<p>Bliss GVS Pharma Ltd. Share Price Today shows a strong session so far, with the stock advancing 3.89% over the previous close and printing a fresh 52-week peak of Rs 596.95. The trading band between Rs 580 and Rs 596.95 indicates firm intraday price action, while turnover of Rs 0.78 crore confirms active market participation.<\/p>\n<p>From the supplied session data, Bliss GVS Pharma Ltd. Share Price opened at Rs 582 against a previous close of Rs 572.7, indicating a positive start. It then moved to an intraday low of Rs 580 before rising to Rs 596.95, which is also the new 52-week high. At the time of the article, the stock was trading at Rs 595.<\/p>\n<p>The absolute gain of Rs 22.3 and percentage rise of 3.89% place the stock among notable Market Movers and Stocks in News within today\u2019s Share Market Today setup. Although the stock did not hold exactly at the day\u2019s high, the difference between the current price of Rs 595 and the peak of Rs 596.95 is narrow, suggesting the stock remained close to its strongest intraday level when this Univest article was prepared.<\/p>\n<p>Trading volume stood at 13,085 shares, while turnover was Rs 0.78 crore. Those figures matter because a 52-week high tends to attract attention not just for the new price level but also for the way participation develops around it. In this case, the verified data establishes a decisive move to a new one-year high. The next step is to judge whether the current valuation and profitability metrics support continued investor attention.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Bliss_GVS_Pharma_Ltd_BLISSGVS-BE_Fundamental_Analysis\"><\/span><strong>Bliss GVS Pharma Ltd. (BLISSGVS-BE) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,796.78 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.87x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">8.31%<\/td>\n<\/tr>\n<\/table>\n<p>Bliss GVS Pharma Ltd. was valued at a P\/E ratio of 48.9x, a P\/B ratio of 1.87x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of -0.78% and ROCE of 8.31%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.65x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.1x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 1,607.56x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.87x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.09%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">8.31%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.29%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,796.78 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 135.91 crore<\/td>\n<\/tr>\n<\/table>\n<p>Bliss GVS Pharma Ltd. (BLISSGVS-BE) is classified under sector: Healthcare.<\/p>\n<p>Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P\/E ratio of 48.9x, which is above the benchmark median of 21.65x, a difference of +125.87%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROE of -0.78%, which is below the benchmark median of 11.09%, a difference of -107.03%. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROCE of 8.31%, which is below the benchmark median of 13.29%, a difference of -37.47%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/indswftlab\/ind-swift-laboratories-ltd-share-price-today\"><strong>Ind-Swift Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">INDSWFTLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3,012.78<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">48.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.87<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.78<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.31<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\"><strong>Dishman Carbogen Amcis Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DCAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,648.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">167.12<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,610.72<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">64.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dragarwq\/dr-agarwals-eye-hospital-ltd-share-price-today\"><strong>Dr Agarwals Eye Hospital Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DRAGARWQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,569.06<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.71<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.95<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">42.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/venusrem\/venus-remedies-ltd-share-price-today\"><strong>Venus Remedies Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">VENUSREM-BE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,417.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.4<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.89<\/td>\n<\/tr>\n<\/table>\n<p>Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P\/E ratio of 48.9x compared with the displayed peer median of 48.9x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.78% compares with a peer median of 9.85% across the companies shown in the table. ROCE stood at 8.31% versus the displayed peer median of 8.31%, providing a capital-efficiency comparison. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a market capitalisation of Rs 5,796.78 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Bliss_GVS_Pharma_Ltd\"><\/span><strong>Why Investors Are Watching Bliss GVS Pharma Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The stock is drawing attention because today\u2019s move combines a fresh one-year high with a meaningful valuation and sector context. The supplied data does not confirm a company-specific trigger, but it does show why the stock has entered the current market conversation.<\/p>\n<ul>\n<li><strong>Fresh price milestone:<\/strong> the stock touched Rs 596.95, its new 52-week high, and was trading at Rs 595, up 3.89% for the day.<\/li>\n<li><strong>Active session:<\/strong> the stock traded between Rs 580 and Rs 596.95 with turnover of Rs 0.78 crore and volume of 13,085 shares.<\/li>\n<li><strong>Large market presence:<\/strong> market capitalisation of Rs 5,796.78 crore is above the supplied sector median and average, and above all listed peers in the snapshot.<\/li>\n<li><strong>Mixed fundamentals:<\/strong> P\/E of 48.9 is near the sector average of 49.1, while ROE of -0.78 and ROCE of 8.31 are below sector medians.<\/li>\n<li><strong>Peer relevance:<\/strong> compared with supplied Healthcare peers, the company stands out more on size than on return ratios.<\/li>\n<\/ul>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Bliss_GVS_Pharma_Ltd\"><\/span><strong>About Bliss GVS Pharma Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Bliss GVS Pharma Ltd. is represented in the supplied dataset as a listed company within the Healthcare sector. The stock is tracked under the symbol BLISSGVS-BE, and the latest market action places it among the names being watched for fresh 52-week highs in the Indian Stock Market.<\/p>\n<p>The available data for this article is centred on market performance, valuation and benchmark comparison rather than a detailed business profile. Even so, the stock\u2019s presence in the Healthcare universe matters because its valuation and return ratios are being assessed against a same-sector sample of 196 companies and a peer list that includes pharmaceutical and healthcare businesses such as Ind-Swift Laboratories, Dishman Carbogen Amcis, Beta Drugs, Dr Agarwals Eye Hospital and Venus Remedies.<\/p>\n<p>For readers following Bliss GVS Pharma Ltd. NSE trends, Bliss GVS Pharma Ltd. BSE commentary, or broader Bliss GVS Pharma Ltd. Company News, the key point is that the stock has reached a fresh yearly high while operating inside a sector where valuations and profitability can vary widely across companies. Univest will continue to place the stock in context through price, valuation and sector comparisons as fresh verified data emerges.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Bliss_GVS_Pharma_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Bliss GVS Pharma Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/blissgvs\/bliss-gvs-pharma-ltd-share-price-today\">Bliss GVS Pharma Ltd. (BLISSGVS-BE) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Investors who follow Bliss GVS Pharma Ltd. Share Price Live can use Univest to track the latest share price movement, 52-week levels, market capitalisation, valuation ratios, sector comparisons and peer positioning in one place. That is especially useful when a stock enters the spotlight after a fresh 52-week high.<\/p>\n<p>On Univest, users can monitor Bliss GVS Pharma Ltd. Shareholding Pattern data when available, review historical price trends, compare market metrics with Healthcare peers, and keep up with Bliss GVS Pharma Ltd. Latest News and verified stock updates. For event-driven tracking, the platform helps place a one-day move in the context of broader stock performance, market cap trends and benchmark valuations without turning the analysis into a recommendation.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_latest_Bliss_GVS_Pharma_Ltd_Share_Price_Today\"><\/span><strong>What is the latest Bliss GVS Pharma Ltd. Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bliss GVS Pharma Ltd. Share Price Today was Rs 595 at the time of this article. The stock was up Rs 22.3 or 3.89% from the previous close of Rs 572.7 during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Bliss_GVS_Pharma_Ltd_Share_Price_rising_today\"><\/span><strong>Why is Bliss GVS Pharma Ltd. Share Price rising today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms that the stock rose 3.89% and touched a fresh 52-week high of Rs 596.95. However, the verified dataset for this article does not establish a company-specific catalyst for the move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_new_52-week_high_of_Bliss_GVS_Pharma_Ltd\"><\/span><strong>What is the new 52-week high of Bliss GVS Pharma Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bliss GVS Pharma Ltd. touched a fresh 52-week high of Rs 596.95 on 20 August 2026. The stock later traded at Rs 595, staying close to its intraday peak during the morning session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_Bliss_GVS_Pharma_Ltd_gain_in_todays_session\"><\/span><strong>How much did Bliss GVS Pharma Ltd. gain in today\u2019s session?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock gained Rs 22.3 in absolute terms and rose 3.89% over its previous close of Rs 572.7. It opened at Rs 582 and traded within an intraday range of Rs 580 to Rs 596.95.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_todays_price_action_show_for_Bliss_GVS_Pharma_Ltd\"><\/span><strong>What does today\u2019s price action show for Bliss GVS Pharma Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Today\u2019s price action shows a positive opening, an intraday low of Rs 580, and a move to a fresh one-year high of Rs 596.95. The stock was trading near that peak at Rs 595.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Bliss_GVS_Pharma_Ltd\"><\/span><strong>What is the market capitalisation of Bliss GVS Pharma Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bliss GVS Pharma Ltd. had a market capitalisation of Rs 5,796.78 crore in the supplied data. That is above the Healthcare sector benchmark median of Rs 135.91 crore and average of Rs 467.67 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_Bliss_GVS_Pharma_Ltd_valued_compared_with_the_Healthcare_sector\"><\/span><strong>How is Bliss GVS Pharma Ltd. valued compared with the Healthcare sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock trades at a P\/E of 48.9 versus the sector median of 21.65 and average of 49.1. Its P\/B of 1.87 is slightly below the sector median of 1.9 and average of 2.6.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_do_the_profitability_ratios_of_Bliss_GVS_Pharma_Ltd_compare_with_the_sector\"><\/span><strong>How do the profitability ratios of Bliss GVS Pharma Ltd. compare with the sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bliss GVS Pharma Ltd. reported ROE of -0.78 and ROCE of 8.31 in the supplied snapshot. Both are below the Healthcare sector median levels of 11.09 for ROE and 13.29 for ROCE.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Bliss_GVS_Pharma_Ltd_compare_with_the_supplied_peers\"><\/span><strong>How does Bliss GVS Pharma Ltd. compare with the supplied peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bliss GVS Pharma Ltd. has the largest market capitalisation at Rs 5,796.78 crore among the supplied peers. Its P\/E of 48.9 is mid-range, while ROE of -0.78 and ROCE of 8.31 trail several peers.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bliss GVS Pharma Ltd. Share Price hits a new 52-week high at Rs 595. marking a 3.89% rise today. Market cap stands at Rs 5,796.78 crore.<\/p>\n","protected":false},"author":29,"featured_media":212959,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-212961","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["212959"],"rank_math_title":["Bliss GVS Pharma Ltd. Share Price at Fresh 52-Week High"],"rank_math_description":["Bliss GVS Pharma Ltd. Share Price reached a new 52-week high. Check today\u2019s move, market cap, valuation ratios and Healthcare sector comparison."],"rank_math_focus_keyword":["Bliss GVS Pharma Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Bliss_GVS_Pharma_Ltd_BLISSGVS_BE_Share_Price_Hits_Fresh_52_Week_High_bullish-2.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/212961","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=212961"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/212961\/revisions"}],"predecessor-version":[{"id":212963,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/212961\/revisions\/212963"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/212959"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=212961"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=212961"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=212961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}